CEO and Founder of Axiom Real-Time Metrics, Andrew Schachter, speaks with PharmaVOICE at DIA 2017 on how small to mid-sized life sciences organizations select EDC vendors, the concept of “Unified” in an eClinical suite, the pain points for end-users, and the evolution of Axiom’s Fusion eClinical Suite.